Article
Using large-scale population-based data to improve disease risk assessment of clinical variants.
Nature genetics - 1 Jul 2025
Forrest Iain S, Huang Kuan-Lin, Eggington Julie M, Chung Wendy K, Jordan Daniel M, Do Ron
Abstract excerpt
Understanding the disease risk of genetic variants is fundamental to precision medicine. Estimates of penetrance-the probability of disease for individuals with a variant allele-rely on disease-specific cohorts, clinical testing and emerging electronic health record (EHR)-linked biobanks. These data sources, while valuable, each have limitations in quality, representativeness and analyzability. Here, we provide a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
